In-Vitro Lung Model Sector Forecast Shows Robust Momentum, Climbing to $1.29 Billion With 18.6% CAGR
The In-Vitro Lung Model market size is expected to reach $1.29 billion in 2030 at a CAGR of 18.6%, driven by increasing clinical studies.
Read More
The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) market size is expected to reach $8.17 billion in 2030 at a CAGR of 6.6%, driven by rising clinical trials.
Read More
The Intravenous Iron Drugs market size is expected to reach $6.34 billion in 2030 at a CAGR of 10.7%, driven by growing chronic kidney disease cases.
Read More
The Intravenous Immunoglobulin market size is expected to reach $23.44 billion in 2030 at a CAGR of 8.6%, driven by increasing geriatric population.
Read More
The Intratumoral Cancer Therapies market size is expected to reach $274.76 billion in 2030 at a CAGR of 12.0%, driven by rising cancer incidence.
Read More
The Intranasal Corticosteroids market size is expected to reach $9.74 billion in 2030 at a CAGR of 7.4%, driven by rising allergic rhinitis prevalence.
Read More
The Interventional Lung Solutions market size is expected to reach $3.66 billion in 2030 at a CAGR of 8.1%, driven by rising respiratory diseases.
Read More
The Interstitial Cystitis Drugs market size is expected to reach $1.82 billion in 2030 at a CAGR of 4.8%, driven by rising chronic diseases.
Read More
The InterLeukin6 IL6 Inhibitor market size is expected to reach $58.33 billion in 2030 at a CAGR of 10.3%, driven by rising neurological disorders.
Read More
The Interleukin Inhibitors Market size is expected to reach $136.99 billion in 2030 at a CAGR of 18.9%, driven by bacterial infection prevalence.
Read More